<DOC>
	<DOCNO>NCT01844739</DOCNO>
	<brief_summary>This 2 week Phase 1 study SB204 ( NVN1000 Gel ) healthy adult volunteer elevate Propionibacterium acne ( P. acne ) count . Subjects apply NVN1000 4 % Gel Vehicle Gel twice daily face . Assessments include cutaneous tolerability , safety , P. acnes count .</brief_summary>
	<brief_title>A Phase 1 Study Evaluating Safety Tolerability NVN1000 Gel</brief_title>
	<detailed_description>In single-center , vehicle gel-controlled , evaluator subject blind study , approximately 30 otherwise healthy adult subject elevate P. acne count randomized 2:1 NVN1000 4 % Gel Vehicle Gel . The subject apply test material twice daily face wash . Subjects see daily skin study center week apply even weekend dose home . Cutaneous tolerability assess Investigator Baseline , Week 1 , Week 2 . Safety assessment include collection adverse event , laboratory result , clinically significant change physical examination . P. acnes count obtain Baseline , Week 1 Week 2 .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>Healthy adult male female volunteer If woman childbearing potential , agree use effective method birth control study 30 day final study visit Agree refrain use antimicrobial topical product study Any skin disorder acute chronic nature include psoriasis , eczema , etc Female subject pregnant , nursing , plan become pregnant Subjects use topical systemic antibiotic , estrogen , drug associate methemoglobinemia , nitrate donor Subjects baseline methemoglobin &gt; 2 % Subjects clinically significant anemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Propionibacterium acne</keyword>
	<keyword>acne</keyword>
</DOC>